The effect of VPA on bone: From clinical studies to cell cultures-The molecular mechanisms revisited.
| Title | The effect of VPA on bone: From clinical studies to cell cultures-The molecular mechanisms revisited. |
| Publication Type | Journal Article |
| Year of Publication | 2017 |
| Authors | Pitetzis, D. A., Spilioti M. G., Yovos J. G., & Yavropoulou M. P. |
| Journal | Seizure |
| Volume | 48 |
| Pagination | 36-43 |
| Date Published | 2017 May |
| ISSN | 1532-2688 |
| Keywords | Animals, Anticonvulsants, Bone and Bones, Bone Diseases, Metabolic, Cells, Cultured, Humans, Valproic Acid, Vitamin D |
| Abstract | PURPOSE: Valproic acid (VPA) is a broad-spectrum antiepileptic drug, which is widely used as a first line treatment for idiopathic and symptomatic generalized epilepsy, as well as in non-epileptic psychiatric disorders in adult and pediatric patients. Although valproic acid is considered to be a generally well-tolerated drug, numerous studies have shown an increased bone loss and fracture risk in patients treated with VPA. The purpose of this review is to outline recent findings on VPA molecular mechanisms and their action on bone metabolism.METHODS: Unrestricted electronic search of medical databases, complemented by additional manual searches, was performed by August 2016.RESULTS/CONCLUSION: The main effects of VPA on bone metabolism involve a decrease in osteoblast proliferation, changes in collagen synthesis as well as an induction of vitamin D catabolism. Apart from these direct actions of VPA in bone, indirect effects affecting other endocrine organs also contribute to VPA-induced bone loss. |
| DOI | 10.1016/j.seizure.2017.03.013 |
| Alternate Journal | Seizure |
| PubMed ID | 28391043 |
